<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/50/1527" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/50/1527/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/50/1527/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1527"><akn:num>1527</akn:num><akn:heading>Improved biosafety for handling of select agents and toxins</akn:heading><akn:content><akn:p>§ 1527. Improved biosafety for handling of select agents and toxins(a) Quality control and quality assurance programThe Secretary of Defense, acting through the executive agent for the biological select agent and toxin biosafety program of the Department of Defense, shall carry out a program to implement certain quality control and quality assurance measures at each covered facility.


(b) Quality control and quality assurance measuresSubject to subsection (c), the quality control and quality assurance measures implemented at each covered facility under subsection (a) shall include the following:(1) Designation of an external manager to oversee quality assurance and quality control.

(2) Environmental sampling and inspection.

(3) Production procedures that prohibit operations where live biological select agents and toxins are used in the same laboratory where viability testing is conducted.

(4) Production procedures that prohibit work on multiple organisms or multiple strains of one organism within the same biosafety cabinet.

(5) A video surveillance program that uses video monitoring as a tool to improve laboratory practices in accordance with regulatory requirements.

(6) Formal, recurring data reviews of production in an effort to identify data trends and nonconformance issues before such issues affect end products.

(7) Validated protocols for production processes to ensure that process deviations are adequately vetted prior to implementation.

(8) Maintenance and calibration procedures and schedules for all tools, equipment, and irradiators.


(c) WaiverIn carrying out the program under subsection (a), the Secretary may waive any of the quality control and quality assurance measures required under subsection (b) in the interest of national defense.


(d) Study and report required(1) StudyThe Secretary of Defense shall carry out a study to evaluate—(A) the feasibility of consolidating covered facilities within a unified command to minimize risk;

(B) opportun</akn:p></akn:content><akn:subsection eId="subsec_1527_a"><akn:num>(a)</akn:num><akn:heading>Quality control and quality assurance program</akn:heading><akn:content><akn:p>(a) Quality control and quality assurance program The Secretary of Defense, acting through the executive agent for the biological select agent and toxin biosafety program of the Department of Defense, shall carry out a program to implement certain quality control and quality assurance measures at each covered facility.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1527_b"><akn:num>(b)</akn:num><akn:heading>Quality control and quality assurance measures</akn:heading><akn:content><akn:p>(b) Quality control and quality assurance measures Subject to subsection (c), the quality control and quality assurance measures implemented at each covered facility under subsection (a) shall include the following:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1527_c"><akn:num>(c)</akn:num><akn:heading>Waiver</akn:heading><akn:content><akn:p>(c) Waiver In carrying out the program under subsection (a), the Secretary may waive any of the quality control and quality assurance measures required under subsection (b) in the interest of national defense.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1527_d"><akn:num>(d)</akn:num><akn:heading>Study and report required</akn:heading><akn:content><akn:p>(d) Study and report required</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1527_e"><akn:num>(e)</akn:num><akn:heading>Comptroller General review</akn:heading><akn:content><akn:p>(e) Comptroller General review Not later than September 1, 2017, the Comptroller General of the United States shall submit to the congressional defense committees a report that includes the following:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1527_f"><akn:num>(f)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(f) Definitions In this section:</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>